Navigation Links
Primary Endpoint Achieved in CAVATAK Phase 2 Melanoma Trial
Date:9/18/2013

SYDNEY, Sept. 18, 2013 /PRNewswire/ -- Viralytics Limited (ASX: VLA, OTCQX: VRACY) has achieved the primary endpoint in its Phase 2 clinical trial of CAVATAKTM in the treatment of late stage melanoma patients (the CALM study).

The Phase 2 trial is a single arm study being conducted at 10 US sites and is designed to investigate the safety and efficacy of intratumoral CAVATAKTM (Coxsackievirus A21) in 54 evaluable1 patients with late stage (IIIc and IV) malignant melanoma.

The primary endpoint measured is immune related Progression Free Survival (irPFS) at six months after first dose of CAVATAK™. Progression Free Survival is the length of time, during and after treatment, that the patient lives with the cancer without it worsening. It includes patients that achieve a complete tumour response2, partial tumour response3 or stable disease4.

The primary endpoint of the study was to have 10 patients from a total of 54 evaluable patients reporting irPFS at six months after the first dose of CAVATAK™.  This was achieved after only 30 evaluable patients, representing an irPFS rate so far of 33%. 

"Achieving the primary endpoint of the CALM study before patient recruitment has been completed is very encouraging. In addition to the positive irPFS data we have observed responses in both injected and non-injected lesions," said Dr Robert Andtbacka, Lead Study Investigator from the Huntsman Cancer Institute in the US.

Dr Malcolm McColl, Chief Executive Officer of Viralytics said: "We are delighted to achieve this major milestone in the development of CAVATAK™. Given the excellent progress achieved to date and the encouraging feedback from key opinion leaders in the melanoma field we also believe it is now timely to consider the design of a randomised study in
'/>"/>

SOURCE Viralytics Ltd.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Elcelyx Therapeutics NewMet for Type 2 Diabetes Meets Primary Endpoint in Phase 2b Study
2. Takeda EXAMINE Cardiovascular Safety Outcomes Trial of Alogliptin Met Primary Endpoint of Non-Inferiority Compared to Placebo in Addition to Standard of Care Showing No Increase in Cardiovascular Risk in Type 2 Diabetes Patients at High-Risk for Car
3. Rigels R343 Did Not Meet Primary Endpoint in Asthma Study
4. ARRY-502 Meets Primary And Key Secondary Endpoints In Asthma Study
5. TREATMENT OF PRIMARY LIVER CANCER: SARAH STUDY NOW AVAILABLE FOR ALL ELIGIBLE PATIENTS THROUGHOUT FRANCE
6. OxThera Strengthens Patent Portfolio for Orphan Disease - Primary Hyperoxaluria
7. Primary Efficacy and Safety Findings from Phase 3 Study of Janssens Simeprevir Administered Once Daily Demonstrate Sustained Virologic Response in Treatment-Experienced Genotype 1 Chronic Hepatitis C Adult Patients
8. Top-line Data Demonstrate Primary Endpoint Achieved in Final Pivotal Phase 3 Study of Sufentanil NanoTab PCA System For Management of Post-Operative Pain
9. Lilly Announces Enzastaurin Phase III Study Did Not Meet Primary Endpoint in Diffuse Large B-Cell Lymphoma
10. Carena Launches 24/7 Virtual Care Delivery Service for Hospital Systems and Primary Care Clinics
11. Top-line Data Show AcelRx Pharmaceuticals ARX-04 Achieves Primary Endpoint in Dose-Finding Phase 2 Clinical Trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2015)... , Jan. 22, 2015 Research and Markets ... "Infectious Disease Diagnostics Market by Product, Application, Technology, ... to their offering. , The infectious disease ... 7.9% to reach $18,156.2 million by 2019 from $12,422.8 ...
(Date:1/22/2015)... ( http://www.researchandmarkets.com/research/w25xpc/allergy ) has announced the addition of ... by End User - Global Forecast to 2019" report ... market is valued at $1,228.58 million in 2014 and is ... $2,230.72 million by 2019. Allergy diagnostics is used to determine ...
(Date:1/22/2015)... ( http://www.researchandmarkets.com/research/tl6pqb/xray_detectors ) has announced the addition of ... by FPD Panel Size - Global Forecast to 2019" ... detectors market is a growing field that has witnessed a ... shift from film to filmless imaging. Hospitals and medical imaging ...
Breaking Medicine Technology:Global Infectious Disease Diagnostics (Instruments, Reagents, Services, Software) Market - Forecast to 2019 2Global Infectious Disease Diagnostics (Instruments, Reagents, Services, Software) Market - Forecast to 2019 3Global Allergy Diagnostics (Immunoassay Analyzer, Luminometer, Assay Kit, Consumables) Market - Forecast to 2019 2Global Allergy Diagnostics (Immunoassay Analyzer, Luminometer, Assay Kit, Consumables) Market - Forecast to 2019 3Global X-Ray Detectors (Flat Panel, Computed Radiography, CCD, Line-Scan) Market - Forecast to 2019 2Global X-Ray Detectors (Flat Panel, Computed Radiography, CCD, Line-Scan) Market - Forecast to 2019 3
... Colorcon, Inc. today announced the acquisition of the full-service ... acquisition expands Colorcon,s global excipient product offerings in the pharmaceutical ... , , ... spheres complements Colorcon,s SureSpheres® sugar spheres product line and barrier ...
... MISSISSAUGA, Ontario , April 22 CardioGenics Inc. (OTC ... segment of the IVD testing market, will be spotlighted in three publications ... Design Technology and The Wall Street Transcript . , ... In the April 2010 ...
Cached Medicine Technology:Colorcon Acquires Pharmaceutical Excipient Company - NP Pharm 2CardioGenics to be Spotlighted in Three Publications During Month of April 2CardioGenics to be Spotlighted in Three Publications During Month of April 3CardioGenics to be Spotlighted in Three Publications During Month of April 4
(Date:1/22/2015)... Boulder, Colorado (PRWEB) January 22, 2015 Four years ... is Queen – which coincided with the marriage of Avasa & ... album, THE ROAD, which is scheduled for release through White Swan ... heartfelt message that there is a sacred path available to all ...
(Date:1/22/2015)... Mass. (PRWEB) January 22, 2015 EBSCO ... (AMA) are expanding their relationship in an effort to ... around the world. While EBSCO has long made AMA journals ... a sales agent for The JAMA Network. , ...
(Date:1/22/2015)... a famous dress online store for wedding dresses and other ... of wedding dresses , and launches a site-wide women’s dress ... on your big day; the wedding gown is the most ... find the most suitable wedding dress. Now, we are proud ...
(Date:1/22/2015)... released a new blog post explaining the importance of keeping a ... of an auto insurance policy . , Clients who driver ... their vehicle insurance policies. The safety a vehicle offers from its ... of this, drivers should always carry a first aid kit in ...
(Date:1/22/2015)... Ga., USA (PRWEB) January 22, 2015 ... a statewide data management system with support from GEOSYSTEMS, ... , The new solution will leverage Hexagon Geospatial’s ... and vector data as well as point clouds and ...
Breaking Medicine News(10 mins):Health News:THE ROAD by Avasa & Matthew Love -- A New Album 2Health News:THE ROAD by Avasa & Matthew Love -- A New Album 3Health News:THE ROAD by Avasa & Matthew Love -- A New Album 4Health News:EBSCO Expands Partnership with the American Medical Association 2Health News:EBSCO Expands Partnership with the American Medical Association 3Health News:EBSCO Expands Partnership with the American Medical Association 4Health News:Find The Most Suitable Wedding Dress At JJsHouse.com 2Health News:Driving Safe And Other Factors That Make Auto Insurance Affordable! 2Health News:State Forestry Institute Mecklenburg-Vorpommern, Germany Embraces Hexagon Geospatial Technology 2Health News:State Forestry Institute Mecklenburg-Vorpommern, Germany Embraces Hexagon Geospatial Technology 3
... to aggressively challenge patents on drugs in the US despite ... generic Omeprazole 40 mg capsules by the US Food and ... and gastric ulcers. ,The FDA granted the marketing exclusivity ... exclusivity is a setback for Dr Reddy’s, but this will ...
... UK scientists say they have discovered molecules in ... action of free radicals.With further research, the research ... degenerative diseases.// Oxidative damage has been linked with ... like arthritis and diabetes, cancer and Alzheimer’s disease. ...
... A new ray of hope for hearing impairment. A new ... better sound quality than a more conventional aid. Doctors say ... loss.//The usual kind of hearing aid transmits sound through the ... - as well as giving the wearer the feeling of ...
... the third leading cause of death in the United States, ... stroke every year, and 167,000 die from it. Men who ... as likely// to die from a stroke as other men. ... to have non-fatal strokes. ,Researchers studied 2000 men aged ...
... is a very easy and simple way to slow down ... and reciting the Rosary respiration rate can be slowed down ... The Rosary// is an important prayer ritual in the Catholic ... ,Researchers at the University of Cleavland, recorded breathing rates ...
... artists are similar to those endured by professional athletes. ... conditioning, often eight to ten hours of practice daily.// ... tremendous amounts of stress in the upper extremities during ... orthopaedic surgery at Harvard Medical School in Boston, at ...
Cached Medicine News:
Facial Mask...
Abdominal Binders - 9" & 12"...
Ideal for abdominal and flank procedures....
CDIs 2nd Stage Abdominoplasty Girdle - a feminine, easy pull-on version of the 8000 series...
Medicine Products: